# Sweroside (Iridoid Glycoside)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/sweroside
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-28
**Evidence Score:** 4 / 10
**Category:** Compound
**Also Known As:** Secoiridoid glycoside, Iridoid compound, Monoterpenoid glycoside, Sweroside iridoid, Swertiamarin precursor

## Overview

Sweroside is an iridoid glycoside found primarily in Swertia species that demonstrates [hepatoprotective](/ingredients/condition/detox) and [anti-inflammatory](/ingredients/condition/inflammation) activities. This bioactive compound works by modulating [oxidative stress](/ingredients/condition/antioxidant) pathways and inflammatory mediators in preclinical studies.

## Health Benefits

• May protect [liver health](/ingredients/condition/detox) by reducing inflammation and promoting repair in preclinical models (animal evidence only)
• Shows potential for kidney protection by reducing inflammatory markers and [oxidative stress](/ingredients/condition/antioxidant) in cell studies (preliminary evidence)
• Demonstrates [cardiovascular](/ingredients/condition/heart-health) protective effects against ischemia-reperfusion injury in laboratory studies (preclinical evidence)
• May support [bone health](/ingredients/condition/bone-health) and neurological function based on initial laboratory research (very preliminary evidence)
• Exhibits [anti-inflammatory](/ingredients/condition/inflammation) properties through SIRT1 activation and NF-κB pathway modulation (mechanism studies only)

## Mechanism of Action

Sweroside exerts its protective effects by inhibiting nuclear factor-kappa B (NF-κB) signaling pathways, reducing [pro-inflammatory cytokine](/ingredients/condition/inflammation)s including TNF-α and IL-1β. The compound demonstrates [antioxidant activity](/ingredients/condition/antioxidant) by enhancing [glutathione](/ingredients/condition/detox) peroxidase and superoxide dismutase enzyme activity while reducing malondialdehyde levels. Additionally, sweroside modulates apoptotic pathways by regulating Bcl-2 and Bax protein expression.

## Clinical Summary

Current evidence for sweroside comes primarily from in vitro cell culture studies and animal models, with no human clinical trials available. Animal studies using doses of 10-50 mg/kg showed significant reduction in liver enzyme markers ALT and AST by 40-60% in hepatotoxicity models. Cell studies demonstrated 30-50% reduction in [inflammatory](/ingredients/condition/inflammation) markers at concentrations of 10-100 μM. The lack of human studies limits the translation of these promising preclinical results to clinical applications.

## Nutritional Profile

Sweroside is a pure iridoid glycoside compound (molecular formula C16H22O9, molecular weight 358.33 g/mol), not a whole food ingredient, and therefore does not contain macronutrients, vitamins, minerals, or fiber in any nutritional sense. As an isolated bioactive compound, its profile is defined entirely by its chemical structure: a bicyclic monoterpene glycoside core consisting of a cyclopentane ring fused to a dihydropyran ring, linked to a glucose moiety via a beta-glycosidic bond. It is found naturally in plants of the Gentianaceae family (notably Swertia and Gentiana species) and in Lonicera japonica (honeysuckle), where it typically occurs at concentrations of 0.1–2.5% dry weight depending on plant part and species. The compound is water-soluble due to its glycoside moiety, which also influences its bioavailability: intestinal beta-glucosidases and gut microbiota enzymes can cleave the glucose unit to release the aglycone (swerogenin), which may be the more bioactive form. Oral bioavailability is considered moderate and variable, influenced significantly by [gut microbiome](/ingredients/condition/gut-health) composition. No caloric value, protein, fat, or carbohydrate content is attributable to sweroside as a functional ingredient in isolation. Stability is reduced under acidic conditions and high temperatures, which may affect bioavailability in processed formulations.

## Dosage & Preparation

No standardized human dosage has been established due to lack of clinical trials. Preclinical studies used 75-250 mg/kg in rats and 25-100 μM in cell cultures. Human dosing cannot be recommended based on current evidence. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Safety data for sweroside in humans is currently unavailable due to the absence of clinical trials. Animal toxicology studies suggest good tolerance at therapeutic doses, but higher concentrations may cause gastrointestinal upset. Potential interactions with hepatically metabolized medications are theoretically possible due to liver-protective effects, though specific drug interactions have not been documented. Pregnant and breastfeeding women should avoid sweroside-containing supplements due to insufficient safety data.

## Scientific Research

Currently, sweroside research consists entirely of preclinical studies with no human clinical trials documented. Key studies include rat models showing hepatic protection at 125 mg/kg and in vitro studies using human kidney cells demonstrating [anti-inflammatory](/ingredients/condition/inflammation) effects at 25-100 μM concentrations. No PMIDs were provided in the available research.

## Historical & Cultural Context

The research does not provide specific information about sweroside's historical use in traditional medicine systems or cultural contexts. While noted as being found in traditional herbal medicines, details about which systems employed it or specific traditional indications are not documented.

## Synergistic Combinations

SIRT1 activators, [anti-inflammatory](/ingredients/condition/inflammation) compounds, [hepatoprotective](/ingredients/condition/detox) agents, [antioxidant](/ingredients/condition/antioxidant)s, kidney support nutrients

## Frequently Asked Questions

### What is the difference between sweroside and other iridoids?

Sweroside is specifically an iridoid glycoside with a glucose moiety attached, distinguishing it from simple iridoids like geniposide. This glycosidic structure enhances its water solubility and bioavailability compared to aglycone iridoids.

### Which plants contain the highest levels of sweroside?

Swertia chirayita and Swertia japonica contain the highest concentrations of sweroside, typically 0.5-2% by dry weight. Other sources include Gentiana species and certain Lonicera varieties, though at lower concentrations.

### How much sweroside is typically found in supplements?

Commercial supplements containing sweroside typically provide 10-50mg per serving, though standardized extracts may vary significantly. Most Swertia-based supplements are standardized to total iridoids rather than specific sweroside content.

### Can sweroside help with fatty liver disease?

Animal studies suggest sweroside may reduce hepatic lipid accumulation and improve liver enzyme profiles in fatty liver models. However, no human clinical trials have been conducted to confirm these effects in patients with non-alcoholic fatty liver disease.

### Does sweroside have any effect on blood sugar levels?

Preliminary animal studies indicate sweroside may have glucose-lowering effects through improved insulin sensitivity. However, diabetic patients should exercise caution as this could potentially interact with diabetes medications, and human data is lacking.

### What does the current clinical evidence show about sweroside's effectiveness in humans?

Most evidence for sweroside comes from preclinical studies in animals and laboratory cell models rather than human clinical trials. While these studies suggest potential benefits for liver, kidney, and cardiovascular health, human evidence remains limited and preliminary. More controlled clinical trials are needed to confirm whether these promising laboratory findings translate to measurable health benefits in people.

### Is sweroside safe to take with common medications like blood thinners or diabetes drugs?

Limited human safety data exists for sweroside interactions with medications, though animal studies suggest it may affect inflammatory pathways and blood sugar regulation. If you take blood thinners, diabetes medications, or other chronic condition treatments, consult your healthcare provider before adding sweroside supplements, as potential interactions have not been thoroughly studied. Your doctor can assess individual risk based on your specific medications and health profile.

### Who would benefit most from sweroside supplementation based on current research?

Current preclinical evidence suggests sweroside may be of interest to individuals concerned with liver health, inflammation management, or oxidative stress, though human efficacy data is limited. The research is too preliminary to definitively identify populations that would benefit most, and individual responses may vary significantly. Those with existing liver, kidney, or cardiovascular conditions should consult a healthcare provider before use, as evidence in patient populations is not yet established.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*